Top

Published in:

01-12-2005 | Original Article

Association between bone mineral densities and serum lipid profiles of pre- and post-menopausal rural women in South Korea

Authors: Lian-Hua Cui, Min-Ho Shin, Eun-Kyung Chung, Young-Hoon Lee, Sun-Seog Kweon, Kyeong-Soo Park, Jin-Su Choi

Published in: Osteoporosis International | Issue 12/2005

Abstract

The objectives of this population-based study were to investigate the potential association between bone mineral density (BMD) and serum lipid profiles and to compare the effects of serum lipids on BMD at various skeletal sites in pre- and post-menopausal women. In July and August of 2004, BMD was measured at a variety of skeletal sites [lumbar spine (L_1–4), femoral neck, trochanter, Ward’s triangle, shaft and proximal total hip] using the GE/Bravo Lunar DPX dual-energy X-ray absorptiometer in a South Korean population-based sample of 375 pre-menopausal and 355 post-menopausal rural women aged 19–80 years. The levels of serum total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) were inversely associated with BMD in both pre- and post-menopausal women. In the pre-menopausal women, correlations were shown only for lumbar 1–4 (TC: r =−0.12, P <0.05; LDL-C: r =−0.12, P <0.05), whereas in the post-menopausal women, no correlation was evident for the lumbar sites. In the post-menopausal subjects, the TC levels showed significant correlations with the BMD values at the trochanter ( r =−0.15, P <0.01), shaft ( r =−0.16, P <0.001) and proximal total hip ( r =−0.15, P <0.01) sites, while the LDL-C levels showed significant correlations with the BMD values at the neck ( r =−0.13, P <0.05), trochanter ( r =−0.21, P <0.001), shaft ( r =−0.20, P <0.001) and proximal total hip ( r =−0.20, P <0.001) sites. The levels of triglyceride (TG) were shown to have a significant positive correlation with BMD values at the trochanter site ( r =0.11, P =0.05) in the post-menopausal women; by contrast, subjects in a higher quartile of TG levels show lower lumbar BMD values in the pre-menopausal women. The levels of high-density lipoprotein cholesterol (HDL-C) were not associated with BMD values at any of the sites in the pre- and post-menopausal subjects. Our data indicate a relationship between BMD values and serum lipid levels and suggest differences between pre- and post-menopausal women in terms of the effects of serum lipids on BMD at various skeletal sites.

Von der Recke P, Hansen MA, Hassager C (1999) The association between low bone mass at the menopause and cardiovascular mortality. Am J Med 106:273–278CrossRefPubMed

Eriksen EF, Colvard DS, Berg NJ, Graham ML, Mann KG, Spelsberg TC, Riggs BL (1988) Evidence of estrogen receptors in normal human osteoblast-like cells. Science 241:84–86PubMed

Oursler MJ, Pederson L, Fitzpatrick L, Riggs BL, Spelsberg T (1994) Human giant cell tumors of the bone (osteoclastomas) are estrogen target cells. Proc Natl Acad Sci USA 91:5227–5231PubMed

Kiel DP, Kauppila LI, Cupples LA, Hannan MT, O’Donnell CJ, Wilson PW (2001) Bone loss and the progression of abdominal aortic calcification over a 25-year period: the Framingham Heart Study. Calcif Tissue Int 68:271–276PubMed

Hak AE, Pols HA, van Hemert AM, Hofman A, Witteman JC (2000) Progression of aortic calcification is associated with metacarpal bone loss during menopause: a population-based longitudinal study. Arterioscler Thromb Vasc Biol 20:1926–1931PubMed

Fleet JC, Hock JM (1994) Identification of osteocalcin mRNA in nonosteoid tissue of rats and humans by reverse transcription-polymerase chain reaction. J Bone Miner Res 9:1565–1573PubMed

Giachelli CM, Liaw L, Murry CE, Schwartz SM, Almeida M (1995) Osteopontin expression in cardiovascular diseases. Ann N Y Acad Sci 760:109–126PubMed

Reid IR, Hague W, Emberson J, Baker J, Tonkin A, Hunt D, MacMahon S, Sharpe N (2001) Effect of pravastatin on frequency of fracture in the LIPID study: secondary analysis of a randomised controlled trial. Long-term intervention with pravastatin in ischaemic disease. Lancet 357:509–512CrossRefPubMed

Mundy G, Garrett R, Harris S, Chan J, Chen D, Rossini G, Boyce B, Zhao M, Gutierrez G (1999) Stimulation of bone formation in vitro and in rodents by statins. Science 286:1946–1949CrossRefPubMed

10.

Edwards CJ, Hart DJ, Spector TD (2000) Oral statins and increased bone-mineral density in postmenopausal women. Lancet 355:2218–2219CrossRefPubMed

11.

Wang PS, Solomon DH, Mogun H, Avorn J (2000) HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients. JAMA 283:3211–3216CrossRefPubMed

12.

Meier CR, Schlienger RG, Kraenzlin ME, Schlegel B, Jick H (2000) HMG-CoA reductase inhibitors and the risk of fractures. JAMA 283:3205–3210CrossRefPubMed

13.

Torgerson DJ, Bell-Syer SE (2001) Hormone replacement therapy and prevention of nonvertebral fractures: a meta-analysis of randomized trials. JAMA 285:2891–2897CrossRefPubMed

14.

Davidson MH, Maki KC, Marx P, Maki AC, Cyrowski MS, Nanavati N, Arce JC (2000) Effects of continuous estrogen and estrogen-progestin replacement regimens on cardiovascular risk markers in postmenopausal women. Arch Intern Med 160:3315–3325CrossRefPubMed

15.

Samelson EJ, Cupples LA, Hannan MT, Wilson PW, Williams SA, Vaccarino V, Zhang Y, Kiel DP (2004) Long-term effects of serum cholesterol on bone mineral density in women and men: the Framingham Osteoporosis Study. Bone 34:557–561CrossRefPubMed

16.

Orozco P (2004) Atherogenic lipid profile and elevated lipoprotein (a) are associated with lower bone mineral density in early postmenopausal overweight women. Eur J Epidemiol 19:1105–1112CrossRefPubMed

17.

Adami S, Braga V, Zamboni M, Gatti D, Rossini M, Bakri J, Battaglia E (2004) Relationship between lipids and bone mass in two cohorts of healthy women and men. Calcif Tissue Int 74:136–142CrossRefPubMed

18.

Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499–502PubMed

19.

Yamaguchi T, Sugimoto T, Yano S, Yamauchi M, Sowa H, Chen Q, Chihara K (2002) Plasma lipids and osteoporosis in postmenopausal women. Endocr J 49:211–217PubMed

20.

Poli A, Bruschi F, Cesana B, Rossi M, Paoletti R, Crosignani PG (2003) Plasma low-density lipoprotein cholesterol and bone mass densitometry in postmenopausal women. Obstet Gynecol 102:922–926CrossRefPubMed

21.

Wu XP, Liao EY, Huang G, Dai RC, Zhang H (2003) A comparison study of the reference curves of bone mineral density at different skeletal sites in native Chinese, Japanese, and American Caucasian women. Calcif Tissue Int 73:122–132CrossRefPubMed

22.

Perez-Castrillon JL, De Luis D, Martin-Escudero JC, Asensio T, del Amo R, Izaola O (2004) Non-insulin-dependent diabetes, bone mineral density, and cardiovascular risk factors. J Diabetes Complications 18:317–321CrossRefPubMed

23.

Tanko LB, Bagger YZ, Nielsen SB, Christiansen C (2003) Does serum cholesterol contribute to vertebral bone loss in postmenopausal women? Bone 32:8–14CrossRefPubMed

24.

Wu LY, Yang TC, Kuo SW, Hsiao CF, Hung YJ, Hsieh CH, Tseng HC, Hsieh AT, Chen TW, Chang JB, Pei D (2003) Correlation between bone mineral density and plasma lipids in Taiwan. Endocr Res 29:317–325CrossRefPubMed

25.

Bartels T, Beitz J, Hein W, Schumann M, Laag L, Beitz A, Szymanski C, Mest HJ (1990) [Changes in the spongiosa density in the femoral head of rabbits in atherosclerosis]. Beitr Orthop Traumatol 37:291–297PubMed

26.

Parhami F, Garfinkel A, Demer LL (2000) Role of lipids in osteoporosis. Arterioscler Thromb Vasc Biol 20:2346–2348PubMed

27.

Parhami F, Morrow AD, Balucan J, Leitinger N, Watson AD, Tintut Y, Berliner JA, Demer LL (1997) Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler Thromb Vasc Biol 17:680–687PubMed

28.

Parhami F, Mody N, Gharavi N, Ballard AJ, Tintut Y, Demer LL (2002) Role of the cholesterol biosynthetic pathway in osteoblastic differentiation of marrow stromal cells. J Bone Miner Res 17:1997–2003PubMed

29.

Broulik PD, Kapitola J (1993) Interrelations between body weight, cigarette smoking and spine mineral density in osteoporotic Czech women. Endocr Regul 27:57–60PubMed

30.

D’Amelio P, Pescarmona GP, Gariboldi A, Isaia GC (2001) High density lipoproteins (HDL) in women with postmenopausal osteoporosis: a preliminary study. Menopause 8:429–432PubMed

31.

Morita R, Yamamoto I, Takada M, Yuu I, Ohta T, Matsushita R, Hamanaka Y (1998) [Recent development and clinical application of bone mineral measurements]. Nippon Rinsho 56:1458–1463PubMed

32.

Arlot ME, Sornay-Rendu E, Garnero P, Vey-Marty B, Delmas PD (1997) Apparent pre- and postmenopausal bone loss evaluated by DXA at different skeletal sites in women: the OFELY cohort. J Bone Miner Res 12:683–690PubMed

33.

Ensrud KE, Palermo L, Black DM, Cauley J, Jergas M, Orwoll ES, Nevitt MC, Fox KM, Cummings SR (1995) Hip and calcaneal bone loss increase with advancing age: longitudinal results from the study of osteoporotic fractures. J Bone Miner Res 10:1778–1787PubMed

34.

Jones G, Nguyen T, Sambrook P, Kelly PJ, Eisman JA (1994) Progressive loss of bone in the femoral neck in elderly people: longitudinal findings from the Dubbo osteoporosis epidemiology study. Bmj 309:691–695PubMed

35.

Tanko LB, Bagger YZ, Christiansen C (2003) Low bone mineral density in the hip as a marker of advanced atherosclerosis in elderly women. Calcif Tissue Int 73:15–20CrossRefPubMed

36.

Tintut Y, Demer LL (2001) Recent advances in multifactorial regulation of vascular calcification. Curr Opin Lipidol 12:555–560CrossRefPubMed

37.

Bostrom K (2001) Insights into the mechanism of vascular calcification. Am J Cardiol 88:20E–22ECrossRefPubMed

38.

Price PA, June HH, Buckley JR, Williamson MK (2001) Osteoprotegerin inhibits artery calcification induced by warfarin and by vitamin D. Arterioscler Thromb Vasc Biol 21:1610–1616PubMed

39.

Bucay N, Sarosi I, Dunstan CR, Morony S, Tarpley J, Capparelli C, Scully S, Tan HL, Xu W, Lacey DL, Boyle WJ, Simonet WS (1998) Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 12:1260–1268PubMed

40.

Bollerslev J, Wilson SG, Dick IM, Islam FM, Ueland T, Palmer L, Devine A, Prince RL (2005) LRP5 gene polymorphisms predict bone mass and incident fractures in elderly Australian women. Bone 36:599–606CrossRefPubMed

41.

Koay MA, Woon PY, Zhang Y, Miles LJ, Duncan EL, Ralston SH, Compston JE, Cooper C, Keen R, Langdahl BL, MacLelland A, O’Riordan J, Pols HA, Reid DM, Uitterlinden AG, Wass JA, Brown MA (2004) Influence of LRP5 polymorphisms on normal variation in BMD. J Bone Miner Res 19:1619–1627PubMed

42.

Gong Y, Slee RB, Fukai N, Rawadi G, Roman-Roman S, Reginato AM, Wang H, Cundy T, Glorieux FH, Lev D, Zacharin M, Oexle K, Marcelino J, Suwairi W, Heeger S, Sabatakos G, Apte S, Adkins WN, Allgrove J, Arslan-Kirchner M, Batch JA, Beighton P, Black GC, Boles RG, Boon LM, Borrone C, Brunner HG, Carle GF, Dallapiccola B, De Paepe A, Floege B, Halfhide ML, Hall B, Hennekam RC, Hirose T, Jans A, Juppner H, Kim CA, Keppler-Noreuil K, Kohlschuetter A, LaCombe D, Lambert M, Lemyre E, Letteboer T, Peltonen L, Ramesar RS, Romanengo M, Somer H, Steichen-Gersdorf E, Steinmann B, Sullivan B, Superti-Furga A, Swoboda W, van den Boogaard MJ, Van Hul W, Vikkula M, Votruba M, Zabel B, Garcia T, Baron R, Olsen BR, Warman ML (2001) LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107:513–523CrossRefPubMed

43.

Kato M, Patel MS, Levasseur R, Lobov I, Chang BH, Glass DA 2nd, Hartmann C, Li L, Hwang TH, Brayton CF, Lang RA, Karsenty G, Chan L (2002) Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J Cell Biol 157:303–314CrossRefPubMed

44.

Witztum JL, Berliner JA (1998) Oxidized phospholipids and isoprostanes in atherosclerosis. Curr Opin Lipidol 9:441–448CrossRefPubMed

Title: Association between bone mineral densities and serum lipid profiles of pre- and post-menopausal rural women in South Korea
Authors: Lian-Hua Cui
Min-Ho Shin
Eun-Kyung Chung
Young-Hoon Lee
Sun-Seog Kweon
Kyeong-Soo Park
Jin-Su Choi
Publication date: 01-12-2005
Publisher: Springer-Verlag
Published in: Osteoporosis International / Issue 12/2005
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI: https://doi.org/10.1007/s00198-005-1977-2

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Association between bone mineral densities and serum lipid profiles of pre- and post-menopausal rural women in South Korea

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 12/2005

Contribution of lean tissue mass to the urban-rural difference in bone mineral density

Reduction of pain and fracture incidence after kyphoplasty: 1-year outcomes of a prospective controlled trial of patients with primary osteoporosis

Reproducibility of bone mineral density measurements using dual X-ray absorptiometry in daily clinical practice

Gender differences in relationships between body composition components, their distribution and bone mineral density: a cross-sectional opposite sex twin study

Reporting of vertebral fractures on spine X-rays

Association of 1.25 vitamin D3 deficiency, disease activity and low bone mass in ankylosing spondylitis